- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jan 31, 2025 | 169.86M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $374.69M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $635.37M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $68.32M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $48.61M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $68.32M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $48.61M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $412.54M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $665.77M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $420.93M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $666.37M |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 144.52M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 135.58M sh |
| Capex | Q3 2025 · Dec 31, 2023 | $210K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$154.53M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $679.34M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $251.81M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $299.87M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $362.49M |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.36 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$1.36 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.36 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$1.36 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $13.22M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $42.46M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$51.42M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$184.02M |
| Net Income | Q3 2025 · Sep 30, 2023 | −$58.66M |
| Net Income | Q3 2025 · Jun 30, 2023 | −$73.94M |